273 related articles for article (PubMed ID: 18426405)
21. Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells.
Ito I; Fixman ED; Asai K; Yoshida M; Gounni AS; Martin JG; Hamid Q
Clin Exp Allergy; 2009 Sep; 39(9):1370-80. PubMed ID: 19522858
[TBL] [Abstract][Full Text] [Related]
22. Dual role of Ski in pancreatic cancer cells: tumor-promoting versus metastasis-suppressive function.
Wang P; Chen Z; Meng ZQ; Fan J; Luo JM; Liang W; Lin JH; Zhou ZH; Chen H; Wang K; Shen YH; Xu ZD; Liu LM
Carcinogenesis; 2009 Sep; 30(9):1497-506. PubMed ID: 19546161
[TBL] [Abstract][Full Text] [Related]
23. The effect of FK506 on transforming growth factor beta signaling and apoptosis in chronic lymphocytic leukemia B cells.
Romano S; Mallardo M; Chiurazzi F; Bisogni R; D'Angelillo A; Liuzzi R; Compare G; Romano MF
Haematologica; 2008 Jul; 93(7):1039-48. PubMed ID: 18492692
[TBL] [Abstract][Full Text] [Related]
24. Is there a relationship between tissue inhibitor of metalloproteinase-1 and transforming growth factor-beta 1 with respect to malignant melanoma progression?
Kurdoglu M; Güllü IH; Akalin I
Med Hypotheses; 2001 Aug; 57(2):238-40. PubMed ID: 11461180
[TBL] [Abstract][Full Text] [Related]
25. Modulation of TGF-beta signaling by EGF-CFC proteins.
Wechselberger C; Bianco C; Strizzi L; Ebert AD; Kenney N; Sun Y; Salomon DS
Exp Cell Res; 2005 Nov; 310(2):249-55. PubMed ID: 16137677
[TBL] [Abstract][Full Text] [Related]
26. SKI pathways inducing progression of human melanoma.
Reed JA; Lin Q; Chen D; Mian IS; Medrano EE
Cancer Metastasis Rev; 2005 Jun; 24(2):265-72. PubMed ID: 15986136
[TBL] [Abstract][Full Text] [Related]
27. Id2 suppression of p15 counters TGF-beta-mediated growth inhibition of melanoma cells.
Schlegel NC; Eichhoff OM; Hemmi S; Werner S; Dummer R; Hoek KS
Pigment Cell Melanoma Res; 2009 Aug; 22(4):445-53. PubMed ID: 19368689
[TBL] [Abstract][Full Text] [Related]
28. Endocytic regulation of TGF-beta signaling.
Chen YG
Cell Res; 2009 Jan; 19(1):58-70. PubMed ID: 19050695
[TBL] [Abstract][Full Text] [Related]
29. Glioblastoma-secreted factors induce IGFBP7 and angiogenesis by modulating Smad-2-dependent TGF-beta signaling.
Pen A; Moreno MJ; Durocher Y; Deb-Rinker P; Stanimirovic DB
Oncogene; 2008 Nov; 27(54):6834-44. PubMed ID: 18711401
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts.
Gao X; He X; Luo B; Peng L; Lin J; Zuo Z
Eur J Pharmacol; 2009 Mar; 606(1-3):115-20. PubMed ID: 19374881
[TBL] [Abstract][Full Text] [Related]
31. TGF-beta and cancer.
Bierie B; Moses HL
Cytokine Growth Factor Rev; 2006; 17(1-2):29-40. PubMed ID: 16289860
[TBL] [Abstract][Full Text] [Related]
32. c-Fos accelerates hepatocyte conversion to a fibroblastoid phenotype through ERK-mediated upregulation of paxillin-Serine178 phosphorylation.
Güller MC; André J; Legrand A; Setterblad N; Mauviel A; Verrecchia F; Daniel F; Bernuau D
Mol Carcinog; 2009 Jun; 48(6):532-44. PubMed ID: 18973190
[TBL] [Abstract][Full Text] [Related]
33. TGF-beta signaling in vascular biology and dysfunction.
Goumans MJ; Liu Z; ten Dijke P
Cell Res; 2009 Jan; 19(1):116-27. PubMed ID: 19114994
[TBL] [Abstract][Full Text] [Related]
34. TGF-beta, neuronal stem cells and glioblastoma.
Golestaneh N; Mishra B
Oncogene; 2005 Aug; 24(37):5722-30. PubMed ID: 16123805
[TBL] [Abstract][Full Text] [Related]
35. TGF-beta induces connexin43 gene expression in normal murine mammary gland epithelial cells via activation of p38 and PI3K/AKT signaling pathways.
Tacheau C; Fontaine J; Loy J; Mauviel A; Verrecchia F
J Cell Physiol; 2008 Dec; 217(3):759-68. PubMed ID: 18668519
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of transforming growth factor-beta-mediated immunosuppression in tumor-draining lymph nodes augments antitumor responses by various immunologic cell types.
Fujita T; Teramoto K; Ozaki Y; Hanaoka J; Tezuka N; Itoh Y; Asai T; Fujino S; Kontani K; Ogasawara K
Cancer Res; 2009 Jun; 69(12):5142-50. PubMed ID: 19491278
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of the expression of c-Ski and SnoN, possible mediators in TGF-beta resistance, in primary cutaneous melanoma.
Boone B; Haspeslagh M; Brochez L
J Dermatol Sci; 2009 Jan; 53(1):26-33. PubMed ID: 18782659
[TBL] [Abstract][Full Text] [Related]
38. Soluble transforming growth factor beta type II receptor attenuates TGF-beta1 activity in human colorectal cancer LoVo cells.
Zhou R; Xiong B; Song H; Liu S; Wang X
Oncol Rep; 2008 Dec; 20(6):1449-56. PubMed ID: 19020727
[TBL] [Abstract][Full Text] [Related]
39. The effect of transforming growth factor beta on human neuroendocrine tumor BON cell proliferation and differentiation is mediated through somatostatin signaling.
Leu FP; Nandi M; Niu C
Mol Cancer Res; 2008 Jun; 6(6):1029-42. PubMed ID: 18567806
[TBL] [Abstract][Full Text] [Related]
40. A novel immunotherapeutic modality with direct hemoperfusion targeting transforming growth factor-beta prolongs the survival of tumor-bearing rats.
Yamamoto Y; Ueda Y; Itoh T; Iwamoto A; Yamagishi H; Shimagaki M; Teramoto K
Oncol Rep; 2006 Dec; 16(6):1277-84. PubMed ID: 17089050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
